Continuing Education

The Impact of PI3K Inhibitors for the Treatment of Patients with Breast Cancer

Jan 09, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. You will need to log in to participate in the activity.

Enduring CME Activity: School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio

Jan 30, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours. Acknowledgment of Commercial Support This activity is supported by educational grants from AstraZeneca; Athenex; Daiichi Sankyo, Inc.; Foundation Medicine, Inc.; Genomic Health, Inc.; Merck & Co., Inc.; and Seattle Genetics, Inc.

School of Breast Oncology® Online Curriculum

Jan 31, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 26.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 26.0 Contact Hours. Acknowledgment of Commercial Support This activity is supported by educational grants from AstraZeneca, Athenex, Daiichi Sankyo Inc., Genentech, Genomic Health, Lilly, MacroGenics Inc., Merck & Co Inc., Novartis Pharmaceuticals Corporation, and Pfizer. For further information concerning Lilly grant funding, visit lillygrantoffice.com.

Oncology Briefings™: Highlights from San Antonio - Clinical Updates in Breast Cancer Care

Feb 28, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Commercial Support This activity is supported by educational grants from AstraZeneca; Athenex; Daiichi Sankyo, Inc.; Foundation Medicine, Inc.; Genomic Health, Inc.; Merck & Co., Inc.; and Seattle Genetics, Inc.

Community Practice Connections™: 3rd Annual Precision Medicine Through Plasma™: Using Liquid Biopsies in Contemporary Oncology Care

Feb 28, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours. Acknowledgment of Commercial Support This activity is supported by educational grants from AstraZeneca, Foundation Medicine, Inc., Guardant Health, Inc., and Novartis Pharmaceuticals Corporation.

Community Practice Connections™: 3rd Annual School of Nursing Oncology™

Sep 30, 2020

Accreditation/Credit Designation Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours. Acknowledgment of Commercial Support This activity is supported by educational grants from AstraZeneca, Celgene Corporation, Exelixis, Genomic Health Inc, Novartis Pharmaceuticals Corporation, and Taiho Oncology.

Community Practice Connections™: 3rd Annual International Congress on Oncology & Pathology™

Aug 30, 2020

Accreditation/Credit Designation Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours. Acknowledgment of Commercial Support This activity is supported by educational grants from AstraZeneca; Daiichi Sankyo; Genomic Health, Inc; Illumina, Inc; Lilly; and Novartis. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Community Practice Connections™ 18th Annual International Congress on the Future of Breast Cancer™

Sep 30, 2020

Accreditation/Credit Designation Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Commercial Support This activity is supported by educational grants from AstraZeneca, Athenex, Daiichi Sankyo Inc, Genentech Inc, Genomic Health Inc, Lilly, Merck & Co Inc, Novartis Pharmaceuticals Corporation, Pfizer Inc, Puma Biotechnology Inc, and Seattle Genetics Inc. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Community Practice Connections™: ASCO Direct™ Highlights – 2019 Official Annual Meeting Review

Aug 30, 2020

Accreditation/Credit Designation Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours. Acknowledgment of Commercial Support This activity is supported by educational grants from Novartis Pharmaceuticals Corporation, Sanofi Genzyme, and Seattle Genetics, Inc.

Clinical Vignette Series: 37th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®

Jan 31, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours. Acknowledgment of Commercial Support This activity is supported by educational grants from AbbVie Inc.; AstraZeneca; Athenex; Celgene Corporation; Daiichi Sankyo, Inc.; Eisai; Exelixis, Inc.; Genomic Health; Incyte Corporation; MacroGenics, Inc.; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Pfizer; Regeneron; Sanofi Genzyme; Seattle Genetics, Inc.; and Taiho Oncology, Inc.

Exploring Future Applications of HER2/3-Targeted Therapies Across Multiple Tumor Types

Jun 16, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Commercial Support This activity is supported by an educational grant from Daiichi Sankyo, Inc.

2019 Year in Review™: Reflecting on Recent Evidence for the Treatment of Breast Cancer

May 15, 2021

Accreditation/Credit Designation Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Support This activity is supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., MacroGenics Inc, and Seattle Genetics Inc.